Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions
Therapeutic Advances in Medical Oncology · 2026-03 · 18
DOI: 10.1177/17588359261432056 ↗Kurz gefasst
Editorial in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 13.03.2026. Verfasst von Prarthna V Bhardwaj und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Oncology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
demonstrated a consistent improvement in PFS and OS compared to the physicians’ choice of treatment (typically chemotherapy), with a 50% reduction in the risk of progression ( n = 1828, hazard ratio (HR) 0.50, 95% confidence interval (CI), 0.36–0.68, I 2 = 82%,
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology Oncology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA.
- Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Breast Oncology Program, Dana-Farber Brigham Cancer Center, 450 Brookline Ave., Boston, MA 02215, USA.
ORCID-Profile: Paolo Tarantino, Ilana Schlam
Zitieren
APA
Bhardwaj, P. V., Tarantino, P., & Schlam, I. (2026). Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions. Therapeutic Advances in Medical Oncology, 18. https://doi.org/10.1177/17588359261432056
Vancouver
Bhardwaj PV, Tarantino P, Schlam I. Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions. Therapeutic Advances in Medical Oncology. 2026;18. doi:10.1177/17588359261432056
BibTeX
@article{Bhardwaj2026,
author = {Bhardwaj, Prarthna V and Tarantino, Paolo and Schlam, Ilana},
title = {Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions},
journal = {Therapeutic Advances in Medical Oncology},
year = {2026},
volume = {18},
doi = {10.1177/17588359261432056}
}
EUVIMED